LabCorp Posts 3 Percent Revenue Growth for Q3 | GenomeWeb

NEW YORK (GenomeWeb News) – Laboratory Corporation of America today reported that its third quarter revenues increased 3 percent year over year, edging past the consensus Wall Street estimate.

The clinical lab giant posted revenues of $1.46 billion for the three months ended Sept. 30, compared to $1.42 billion for the third quarter of 2012. Analysts, on average, had expected revenues of $1.45 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.